Edman degradation

Revision as of 15:34, 12 June 2009 by Brian Blank (Talk | contribs)

Jump to: navigation, search

WikiDoc Resources for

Edman degradation

Articles

Most recent articles on Edman degradation

Most cited articles on Edman degradation

Review articles on Edman degradation

Articles on Edman degradation in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Edman degradation

Images of Edman degradation

Photos of Edman degradation

Podcasts & MP3s on Edman degradation

Videos on Edman degradation

Evidence Based Medicine

Cochrane Collaboration on Edman degradation

Bandolier on Edman degradation

TRIP on Edman degradation

Clinical Trials

Ongoing Trials on Edman degradation at Clinical Trials.gov

Trial results on Edman degradation

Clinical Trials on Edman degradation at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Edman degradation

NICE Guidance on Edman degradation

NHS PRODIGY Guidance

FDA on Edman degradation

CDC on Edman degradation

Books

Books on Edman degradation

News

Edman degradation in the news

Be alerted to news on Edman degradation

News trends on Edman degradation

Commentary

Blogs on Edman degradation

Definitions

Definitions of Edman degradation

Patient Resources / Community

Patient resources on Edman degradation

Discussion groups on Edman degradation

Patient Handouts on Edman degradation

Directions to Hospitals Treating Edman degradation

Risk calculators and risk factors for Edman degradation

Healthcare Provider Resources

Symptoms of Edman degradation

Causes & Risk Factors for Edman degradation

Diagnostic studies for Edman degradation

Treatment of Edman degradation

Continuing Medical Education (CME)

CME Programs on Edman degradation

International

Edman degradation en Espanol

Edman degradation en Francais

Business

Edman degradation in the Marketplace

Patents on Edman degradation

Experimental / Informatics

List of terms related to Edman degradation

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Edman degradation, developed by Pehr Edman, is a method of sequencing amino acids in a peptide. In this method, the amino-terminal residue is labeled and cleaved from the peptide without disrupting the peptide bonds between other amino acid residues.

Mechanism for Edman Degradation

Phenylisothiocyanate is reacted with an uncharged terminal amino group, under mildly alkaline conditions, to form a phenylthiocarbamoyl derivative. Then, under acidic conditions, this derivative of the terminal amino acid is cleaved as a thiazolinone derivative. The thiazolinone amino acid is then selectively extracted into an organic solvent and treated with acid to form the more stable phenylthiohydantoin (PTH)- amino acid derivative that can be identified by using chromatography or electrophoresis. This procedure can then be repeated again to identify the next amino acid. A major drawback to this technique is that the peptides being sequenced in this manner cannot have more than 50 to 60 residues. This is because the Edman degradation reaction is not 100% efficient, meaning that the cleavage step does not occur every time. However, this problem can be resolved by cleaving large peptides into smaller peptides before proceeding with the reaction. It is able to accurately sequence up to 30 amino acids with 98% efficiency per amino acid. An advantage of the Edman degradation is that it only uses 10 - 100 picomoles of peptide for the sequencing process. Edman degradation reaction is automated to speed up the process. [1]

Bergmann Degradation

An older related method for the stepwise degradation of polypeptides involving azides is the Bergmann Degradation [2] [3].

References

  1. Automated Edman degradation: the protein sequenator. Methods Enzymol. 1973;27:942-1010.
  2. M. Bergmann, Science 79, 439 (1934)
  3. drugfuture.com Link
Cost Effectiveness of Edman degradation

| group5 = Clinical Trials Involving Edman degradation | list5 = Ongoing Trials on Edman degradation at Clinical Trials.govTrial results on Edman degradationClinical Trials on Edman degradation at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Edman degradation | list6 = US National Guidelines Clearinghouse on Edman degradationNICE Guidance on Edman degradationNHS PRODIGY GuidanceFDA on Edman degradationCDC on Edman degradation


| group7 = Textbook Information on Edman degradation | list7 = Books and Textbook Information on Edman degradation


| group8 = Pharmacology Resources on Edman degradation | list8 = AND (Dose)}} Dosing of Edman degradationAND (drug interactions)}} Drug interactions with Edman degradationAND (side effects)}} Side effects of Edman degradationAND (Allergy)}} Allergic reactions to Edman degradationAND (overdose)}} Overdose information on Edman degradationAND (carcinogenicity)}} Carcinogenicity information on Edman degradationAND (pregnancy)}} Edman degradation in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Edman degradation


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Edman degradation | list9 = AND (pharmacogenomics)}} Genetics of Edman degradationAND (pharmacogenomics)}} Pharmacogenomics of Edman degradationAND (proteomics)}} Proteomics of Edman degradation


| group10 = Newstories on Edman degradation | list10 = Edman degradation in the newsBe alerted to news on Edman degradationNews trends on Edman degradation</small>


| group11 = Commentary on Edman degradation | list11 = Blogs on Edman degradation

| group12 = Patient Resources on Edman degradation | list12 = Patient resources on Edman degradationDiscussion groups on Edman degradationPatient Handouts on Edman degradationDirections to Hospitals Treating Edman degradationRisk calculators and risk factors for Edman degradation


| group13 = Healthcare Provider Resources on Edman degradation | list13 = Symptoms of Edman degradationCauses & Risk Factors for Edman degradationDiagnostic studies for Edman degradationTreatment of Edman degradation

| group14 = Continuing Medical Education (CME) Programs on Edman degradation | list14 = CME Programs on Edman degradation

| group15 = International Resources on Edman degradation | list15 = Edman degradation en EspanolEdman degradation en Francais

| group16 = Business Resources on Edman degradation | list16 = Edman degradation in the MarketplacePatents on Edman degradation

| group17 = Informatics Resources on Edman degradation | list17 = List of terms related to Edman degradation


}} de:Edman-Abbau


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox
In other languages